1. Home
  2. NTWK vs BCTX Comparison

NTWK vs BCTX Comparison

Compare NTWK & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$3.28

Market Cap

34.2M

Sector

Technology

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.89

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
BCTX
Founded
1997
2014
Country
United States
Canada
Employees
N/A
4
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2M
28.8M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
NTWK
BCTX
Price
$3.28
$4.89
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
27.4K
875.9K
Earning Date
02-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$66,501,654.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
$77.39
N/A
Revenue Growth
7.70
N/A
52 Week Low
$2.14
$4.10
52 Week High
$5.75
$98.20

Technical Indicators

Market Signals
Indicator
NTWK
BCTX
Relative Strength Index (RSI) 54.85 41.08
Support Level $3.02 $4.10
Resistance Level $3.17 $4.56
Average True Range (ATR) 0.15 0.62
MACD 0.02 -0.10
Stochastic Oscillator 55.43 10.69

Price Performance

Historical Comparison
NTWK
BCTX

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: